Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasm Follicular 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × OTHER × strontium chloride × Clear all
NCT05466812 2022-07-20

Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases

Peking Union Medical College Hospital

Phase 4 Unknown
20 enrolled
Head & Neck

Thyroid Neoplasm Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡